Advertisement
Screener

ZIVO BIOSCIENCE, INC. (ZIVO) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum

ZIVO BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum

ZIVO BIOSCIENCE, INC. (ZIVO) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 4.29% for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2024-11-14

  • ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2024-06-30 was 4.29%, a 10.57% increase year-over-year.
  • ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2023-06-30 was 3.88%.
  • ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2017-03-31 was 1.93%, a 98.97% increase year-over-year.
  • ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2016-03-31 was 0.97%.
  • ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2023 was 3.73%.
  • ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2016 was 1.04%, a 40.57% decline from fiscal 2015.
  • ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2015 was 1.75%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month
2024-09-304.29%
10-Q · filed 2024-11-14
2024-06-304.29%
10-Q · filed 2024-08-14
4.29%
10-Q · filed 2024-08-14
2023-12-313.73%
10-K · filed 2024-03-15
2023-09-303.88%
10-Q · filed 2024-11-14
2023-06-303.88%
10-Q · filed 2024-08-14
3.88%
10-Q · filed 2024-08-14
2017-03-311.93%
10-Q · filed 2017-05-12
2016-12-311.04%
10-K · filed 2017-03-31
2016-09-300.97%
10-Q · filed 2016-11-14
2016-06-300.97%
10-Q · filed 2016-08-12
2016-03-310.97%
10-Q · filed 2017-05-12
2015-12-311.75%
10-K · filed 2017-03-31
2015-09-301.75%
10-Q · filed 2016-11-14
2015-06-301.75%
10-Q · filed 2016-08-12